Ken Griffin Titan Pharmaceuticals Inc Transaction History

Citadel Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.65 - $0.82 $19,288 - $24,333	29,675 New	29,675 $19,000
Q3 2022 Nov 14, 2022	BUY	$0.53 - $22.6 $6,930 - $295,517	13,076 New	13,076 $14,000
Q2 2021 Aug 16, 2021	BUY	$2.24 - $2.9 $111,171 - $143,927	49,630 Added 257.44%	68,908 $179,000
Q1 2021 May 17, 2021	SELL	$2.66 - $4.23 $8,597 - $13,671	-3,232 Reduced 14.36%	19,278 $57,000
Q4 2020 Feb 16, 2021	BUY	$3.0 - $6.0 $67,530 - $135,060	22,510 New	22,510 $74,000

Ticker TTNP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,629,200
Market Cap $49.4M
Description
Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform. The company offers Probuphine implant for the maintenance treatment of opioid use disorder in clinically stable patients in Canada and the Euro...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.